
Niloofar Rahmani
Examiner (ID: 12602, Phone: (571)272-4329 , Office: P/1625 )
| Most Active Art Unit | 1625 |
| Art Unit(s) | 1625, 1691, 1621 |
| Total Applications | 2303 |
| Issued Applications | 1739 |
| Pending Applications | 128 |
| Abandoned Applications | 466 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5711094
[patent_doc_number] => 20060052439
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-09
[patent_title] => 'Salvinorin derivatives and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/079825
[patent_app_country] => US
[patent_app_date] => 2005-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 17098
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0052/20060052439.pdf
[firstpage_image] =>[orig_patent_app_number] => 11079825
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/079825 | Salvinorin derivatives and uses thereof | Mar 13, 2005 | Issued |
Array
(
[id] => 483878
[patent_doc_number] => 07220871
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-05-22
[patent_title] => 'Intermediates for the hemisynthesis of taxanes and preparation processes therefor'
[patent_app_type] => utility
[patent_app_number] => 11/076856
[patent_app_country] => US
[patent_app_date] => 2005-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14797
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/220/07220871.pdf
[firstpage_image] =>[orig_patent_app_number] => 11076856
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/076856 | Intermediates for the hemisynthesis of taxanes and preparation processes therefor | Mar 10, 2005 | Issued |
Array
(
[id] => 4676969
[patent_doc_number] => 20080214600
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-04
[patent_title] => 'Quaternized Quinuclidine Esters'
[patent_app_type] => utility
[patent_app_number] => 10/592787
[patent_app_country] => US
[patent_app_date] => 2005-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17054
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20080214600.pdf
[firstpage_image] =>[orig_patent_app_number] => 10592787
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/592787 | Quaternized Quinuclidine Esters | Mar 9, 2005 | Abandoned |
Array
(
[id] => 232839
[patent_doc_number] => 07598264
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-10-06
[patent_title] => 'HIV integrase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 10/587682
[patent_app_country] => US
[patent_app_date] => 2005-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 60391
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/598/07598264.pdf
[firstpage_image] =>[orig_patent_app_number] => 10587682
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/587682 | HIV integrase inhibitors | Mar 8, 2005 | Issued |
Array
(
[id] => 5178069
[patent_doc_number] => 20070179129
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-02
[patent_title] => 'Opioid receptor antagonists'
[patent_app_type] => utility
[patent_app_number] => 10/598690
[patent_app_country] => US
[patent_app_date] => 2005-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13485
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0179/20070179129.pdf
[firstpage_image] =>[orig_patent_app_number] => 10598690
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/598690 | Opioid receptor antagonists | Mar 7, 2005 | Issued |
Array
(
[id] => 602515
[patent_doc_number] => 07432278
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-10-07
[patent_title] => 'Dicationic imidazo[1,2-a]pyridines and 5,6,7,8-tetrahydro-imidazo[1,2-a]pyridines as antiprotozoal agents'
[patent_app_type] => utility
[patent_app_number] => 11/074565
[patent_app_country] => US
[patent_app_date] => 2005-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19820
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/432/07432278.pdf
[firstpage_image] =>[orig_patent_app_number] => 11074565
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/074565 | Dicationic imidazo[1,2-a]pyridines and 5,6,7,8-tetrahydro-imidazo[1,2-a]pyridines as antiprotozoal agents | Mar 7, 2005 | Issued |
Array
(
[id] => 555535
[patent_doc_number] => 07160919
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-01-09
[patent_title] => 'C7 lactyloxy-substituted taxanes'
[patent_app_type] => utility
[patent_app_number] => 11/071912
[patent_app_country] => US
[patent_app_date] => 2005-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8018
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/160/07160919.pdf
[firstpage_image] =>[orig_patent_app_number] => 11071912
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/071912 | C7 lactyloxy-substituted taxanes | Mar 3, 2005 | Issued |
Array
(
[id] => 5070187
[patent_doc_number] => 20070191289
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-16
[patent_title] => 'Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs'
[patent_app_type] => utility
[patent_app_number] => 10/591757
[patent_app_country] => US
[patent_app_date] => 2005-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47993
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0191/20070191289.pdf
[firstpage_image] =>[orig_patent_app_number] => 10591757
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/591757 | Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs | Mar 2, 2005 | Issued |
Array
(
[id] => 5220328
[patent_doc_number] => 20070161639
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-12
[patent_title] => 'Hiv integrase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 10/587601
[patent_app_country] => US
[patent_app_date] => 2005-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30414
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0161/20070161639.pdf
[firstpage_image] =>[orig_patent_app_number] => 10587601
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/587601 | Hiv integrase inhibitors | Feb 28, 2005 | Abandoned |
Array
(
[id] => 7256846
[patent_doc_number] => 20050143413
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-30
[patent_title] => 'Amido ether substituted imidazoquinolines'
[patent_app_type] => utility
[patent_app_number] => 11/068207
[patent_app_country] => US
[patent_app_date] => 2005-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20628
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20050143413.pdf
[firstpage_image] =>[orig_patent_app_number] => 11068207
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/068207 | Amido ether substituted imidazoquinolines | Feb 27, 2005 | Issued |
Array
(
[id] => 7257094
[patent_doc_number] => 20050143447
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-30
[patent_title] => 'C10 heterosubstituted acetate taxane compositions'
[patent_app_type] => utility
[patent_app_number] => 11/068166
[patent_app_country] => US
[patent_app_date] => 2005-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12857
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20050143447.pdf
[firstpage_image] =>[orig_patent_app_number] => 11068166
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/068166 | C10 heterosubstituted acetate taxane compositions | Feb 27, 2005 | Issued |
Array
(
[id] => 7075351
[patent_doc_number] => 20050148619
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-07
[patent_title] => 'Sulfonamido ether substituted imidazoquinolines'
[patent_app_type] => utility
[patent_app_number] => 11/069033
[patent_app_country] => US
[patent_app_date] => 2005-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16543
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20050148619.pdf
[firstpage_image] =>[orig_patent_app_number] => 11069033
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/069033 | Sulfonamido ether substituted imidazoquinolines | Feb 27, 2005 | Issued |
Array
(
[id] => 5705933
[patent_doc_number] => 20060194981
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-31
[patent_title] => 'Process for preparation of probucol derivatives'
[patent_app_type] => utility
[patent_app_number] => 11/069165
[patent_app_country] => US
[patent_app_date] => 2005-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2146
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0194/20060194981.pdf
[firstpage_image] =>[orig_patent_app_number] => 11069165
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/069165 | Process for preparation of probucol derivatives | Feb 25, 2005 | Abandoned |
Array
(
[id] => 527122
[patent_doc_number] => 07183312
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-02-27
[patent_title] => 'Taxanes having a C7 heterosubstituted acetate substituent'
[patent_app_type] => utility
[patent_app_number] => 11/063626
[patent_app_country] => US
[patent_app_date] => 2005-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12549
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/183/07183312.pdf
[firstpage_image] =>[orig_patent_app_number] => 11063626
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/063626 | Taxanes having a C7 heterosubstituted acetate substituent | Feb 22, 2005 | Issued |
Array
(
[id] => 559586
[patent_doc_number] => 07157492
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-01-02
[patent_title] => 'Dibenzo chromene derivatives and their use as ERβ selective ligands'
[patent_app_type] => utility
[patent_app_number] => 11/064397
[patent_app_country] => US
[patent_app_date] => 2005-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25202
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/157/07157492.pdf
[firstpage_image] =>[orig_patent_app_number] => 11064397
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/064397 | Dibenzo chromene derivatives and their use as ERβ selective ligands | Feb 22, 2005 | Issued |
Array
(
[id] => 884612
[patent_doc_number] => 07351704
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-04-01
[patent_title] => 'Indazole-carboxamide compounds as 5-HT4 receptor agonists'
[patent_app_type] => utility
[patent_app_number] => 11/060195
[patent_app_country] => US
[patent_app_date] => 2005-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23948
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/351/07351704.pdf
[firstpage_image] =>[orig_patent_app_number] => 11060195
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/060195 | Indazole-carboxamide compounds as 5-HT4 receptor agonists | Feb 16, 2005 | Issued |
Array
(
[id] => 5211076
[patent_doc_number] => 20070249660
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-25
[patent_title] => 'Pharmacologically Acceptable Salts of Clopidogrel'
[patent_app_type] => utility
[patent_app_number] => 10/590391
[patent_app_country] => US
[patent_app_date] => 2005-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 4800
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0249/20070249660.pdf
[firstpage_image] =>[orig_patent_app_number] => 10590391
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/590391 | Pharmacologically Acceptable Salts of Clopidogrel | Feb 15, 2005 | Abandoned |
Array
(
[id] => 7005786
[patent_doc_number] => 20050171099
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-04
[patent_title] => '3-(diheteroarylmethylene)-8-azabicyclo[3.2.1]octane and 3-((aryl)(heteroaryl)methylene)-8-azabicyclo[3.2.1]octane derivatives'
[patent_app_type] => utility
[patent_app_number] => 11/048976
[patent_app_country] => US
[patent_app_date] => 2005-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15618
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20050171099.pdf
[firstpage_image] =>[orig_patent_app_number] => 11048976
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/048976 | 3-(diheteroarylmethylene)-8-azabicyclo[3.2.1]octane and 3-((aryl)(heteroaryl)methylene)-8-azabicyclo[3.2.1]octane derivatives | Feb 1, 2005 | Issued |
Array
(
[id] => 5285689
[patent_doc_number] => 20090099364
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-16
[patent_title] => 'Process for preparation of 1-(2s,3s)-2-benzhydryl-n-(5- tert-butyl-2-methoxybenzyl)quinuclidin-3-amine'
[patent_app_type] => utility
[patent_app_number] => 10/588049
[patent_app_country] => US
[patent_app_date] => 2005-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6738
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20090099364.pdf
[firstpage_image] =>[orig_patent_app_number] => 10588049
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/588049 | Process for preparation of 1-(2s,3s)-2-benzhydryl-n-(5- tert-butyl-2-methoxybenzyl)quinuclidin-3-amine | Jan 25, 2005 | Abandoned |
Array
(
[id] => 5361651
[patent_doc_number] => 20090036445
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-05
[patent_title] => 'KINASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 10/597283
[patent_app_country] => US
[patent_app_date] => 2005-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24705
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0036/20090036445.pdf
[firstpage_image] =>[orig_patent_app_number] => 10597283
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/597283 | Kinase inhibitors | Jan 24, 2005 | Issued |